These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 287938)

  • 1. Does aspirin have a prophylactic vascular effect?
    N Z Med J; 1979 Mar; 89(631):176-7. PubMed ID: 287938
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of aspirin in the prevention of cardiovascular and cerebrovascular disease.
    Long K; Long R
    Nurse Pract Forum; 1992 Jun; 3(2):58-9. PubMed ID: 1392672
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aspirin against aging? For whom and how much?].
    Oelz O; Meier PJ
    Ther Umsch; 1990 Aug; 47(8):648-52. PubMed ID: 2218966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and vascular disease--an update.
    Med J Malaysia; 1988 Sep; 43(3):267-8. PubMed ID: 3241590
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic aspirin and the elderly population.
    Dalen JE; Goldberg RJ
    Clin Geriatr Med; 1992 Feb; 8(1):119-26. PubMed ID: 1576570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acetylsalicylic acid in the treatment of cardiovascular and cerebrovascular diseases].
    Landmark K
    Tidsskr Nor Laegeforen; 1997 Dec; 117(30):4432-6. PubMed ID: 9456592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M
    Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
    [No Abstract]   [Full Text] [Related]  

  • 9. [Community control of cardiovascular diseases in Beijing].
    Wu YK; Yu JS; Yu MC; Lu CQ; Gao RQ; He GQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982; 4(2):105-8. PubMed ID: 6216004
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic drug therapy in cerebrovascular disease.
    Unwin DH; Greenlee RG
    Am Fam Physician; 1993 Jul; 48(1):85-90. PubMed ID: 8322647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aspirin for primary prevention of asymptomatic atherosclerosis].
    Lévesque H
    J Mal Vasc; 2002 Dec; 27(5):263-6. PubMed ID: 12525771
    [No Abstract]   [Full Text] [Related]  

  • 12. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 13. A five-year report (1975-1979) of a cardiovascular community control program in the Shijingshan District of Beijing.
    Wu YK; Yu JS; Yu MZ; Lu CQ; Gao RQ; He GQ
    Chin Med J (Engl); 1982 Mar; 95(3):163-6. PubMed ID: 6807622
    [No Abstract]   [Full Text] [Related]  

  • 14. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin all round?
    Orme M
    Br Med J (Clin Res Ed); 1988 Jan; 296(6618):307-8. PubMed ID: 3125876
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of risk profiles for cardiovascular events: implications for prevention.
    Kannel WB; Wilson PW
    Adv Intern Med; 1997; 42():39-66. PubMed ID: 9048116
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aspirin and coronary heart disease].
    Dubach P
    Schweiz Rundsch Med Prax; 1988 Sep; 77(37):961-2. PubMed ID: 3175422
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of outpatient polyclinic institutions in providing the mass prophylaxis of cardiovascular diseases].
    Oganov RG; Glazunov IS
    Ter Arkh; 1985; 57(1):6-9. PubMed ID: 3983847
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology and prevention of cardiovascular diseases].
    Jánosi A
    Orv Hetil; 2005 Apr; 146(15):683-8. PubMed ID: 15895792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.